Daniel Skovronsky

At-a-Glance

Serves as Chief Scientific and Product Officer and President of Lilly Research Laboratories at Eli Lilly and Company.
Founded Avid Radiopharmaceuticals, a company dedicated to developing imaging tools for Alzheimer’s disease.
Leads teams responsible for translating scientific ideas into medicines and oversees global business development efforts at Lilly.
Has worked across discovery, development, and clinical research since joining Eli Lilly in 2010.

Biography

Daniel Skovronsky is the Chief Scientific and Product Officer and President of Lilly Research Laboratories at Eli Lilly and Company. In this role, he leads teams that transform scientific ideas into real-world medicines and oversees global business development efforts, integrating science, strategy, and collaboration to advance medical innovation.

Skovronsky's journey with Eli Lilly began in 2010 following the acquisition of Avid Radiopharmaceuticals, a company he founded.